3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
29
Neoplasms
10
Brain Neoplasms
6
Neoplasm Metastasis
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Skin Neoplasms
2
Multiple Myeloma
2
Hematologic Neoplasms
2
Glioma
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Carcinoma, Anaplastic
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligodendroglioma
1
Nonseminomatous germ cell tumor
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Lymphoma
1
Leukemia, Hairy Cell
1
Histiocytosis, Langerhans-Cell
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Ganglioneuroma
1
Ganglioglioma
1
Fever
1
Differentiated Thyroid Cancer (DTC)
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Astrocytoma
1
Interventions
blinatumomab
6
Cyclophosphamide
5
Rituximab
4
Tacrolimus
3
ponatinib
2
fludarabine
2
denileukin diftitox
2
Vorinostat
2
Vincristine
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Everolimus
2
Etoposide
2
Doxorubicin
2
Darbepoetin alfa
2
Cytarabine
2
Busulfan
2
Brentuximab Vedotin
2
Antilymphocyte Serum
2
Alemtuzumab
2
tetulomab tetraxetan lu-177
1
ruxolitinib
1
pembrolizumab
1
pegaspargase
1
ibrutinib
1
ibritumomab tiuxetan
1
fludarabine phosphate
1
ferrous sulfate
1
ferric gluconate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoproliferative Disorders
×
dabrafenib
×
Clear all
No trials found.